Skip to content

Legal status · United States

Is DT2216 legal in the United States?

Written by Reviewed Sep 2026

Not approvedLongevityStudies in people cited: 4

Direct answer

No. DT2216 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
20
Found nothing
0

Legal category

Investigational, not approved

FDA approval and compounding status, from the DT2216 profile.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

DT2216 in the United States at a glance

Legal categoryInvestigational, not approved
FDA approval statusNot approved. Still being tested as a cancer drug. The first early safety study in people is done. It set a dose for mid-stage studies of 0.4 mg/kg, given into a vein twice a week. No study for ageing or for clearing worn-out cells is registered.
Studies in people4 of 6 sources on the profile
ReviewedSep 2026

The legal category and note come from the DT2216 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.

What this means

  • 01

    DT2216 is being tested in registered clinical trials (official studies in people). FDA has not approved it for sale in the United States.

  • 02

    The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.

What DT2216 is

Built to fix navitoclax's platelet problem. It hands the target protein to a cell tool that platelets barely have. In its first study, in 20 people with solid cancers, only one had a dose-limiting problem: a severe platelet drop that cleared within 48 hours.

Navitoclax kills worn-out cells and platelets, the blood cells that stop bleeding, by hitting the same protein, BCL-xL. DT2216 was designed around that.

How it works: Shown in human cells and mice, with the platelet sparing now backed by the first study in people: DT2216 grabs BCL-xL and pulls in a cell tool called VHL. VHL tags BCL-xL so the cell destroys it.

Approval history: Not approved. Still being tested as a cancer drug. The first early safety study in people is done. It set a dose for mid-stage studies of 0.4 mg/kg, given into a vein twice a week. No study for ageing or for clearing worn-out cells is registered.

How FDA treats this kind of product

Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.

The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for DT2216 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check FDA directly

DT2216 in sport and the military

Whether DT2216 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up DT2216 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

DT2216 in other countries

Frequently asked questions

Is DT2216 legal in the United States?

No. DT2216 is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

Can I buy DT2216 in the United States?

There is no approved product to buy. In the United States, DT2216 has the legal category "Investigational, not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.

Is DT2216 FDA approved?

No. FDA status: Not approved. Still being tested as a cancer drug. The first early safety study in people is done. It set a dose for mid-stage studies of 0.4 mg/kg, given into a vein twice a week. No study for ageing or for clearing worn-out cells is registered.. Current US legal category: "Investigational, not approved". On the evidence, 1 completed human trial is cited on its profile.

Related compounds in the United States

Full research profile

How DT2216 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

DT2216 profile

This page is general information about the legal status of DT2216 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.